questionsmedicales.fr
Structures virales
Virion
Virion : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Tests de diagnostic
Virion
Microscopie électronique
Virus
Tests sérologiques
Anticorps
Symptômes
5
Infection virale
Symptômes
Variabilité des symptômes
Virus
Période d'incubation
Infection virale
Symptômes neurologiques
Virus
Prévention
5
Masques
Transmission virale
Hygiène personnelle
Prévention
Traitements
5
Antibiotiques
Infection virale
Traitement symptomatique
Infection virale
Résistance virale
Antiviraux
Complications
5
Complications
Infection virale
Maladies chroniques
Virus
Gestion des complications
Traitement
Variabilité des complications
Virus
Facteurs de risque
5
Facteurs de risque
Infection virale
Stress
Système immunitaire
Maladies chroniques
Infection virale
Environnement
Infection virale
Habitudes alimentaires
Système immunitaire
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Virion : Questions médicales les plus fréquentes",
"headline": "Virion : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Virion : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-12",
"dateModified": "2025-03-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Virion"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Structures virales",
"url": "https://questionsmedicales.fr/mesh/D056224",
"about": {
"@type": "MedicalCondition",
"name": "Structures virales",
"code": {
"@type": "MedicalCode",
"code": "D056224",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A21"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Nucléocapside",
"alternateName": "Nucleocapsid",
"url": "https://questionsmedicales.fr/mesh/D019251",
"about": {
"@type": "MedicalCondition",
"name": "Nucléocapside",
"code": {
"@type": "MedicalCode",
"code": "D019251",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A21.249.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Capside",
"alternateName": "Capsid",
"url": "https://questionsmedicales.fr/mesh/D002213",
"about": {
"@type": "MedicalCondition",
"name": "Capside",
"code": {
"@type": "MedicalCode",
"code": "D002213",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A21.249.500.250"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Enveloppe virale",
"alternateName": "Viral Envelope",
"url": "https://questionsmedicales.fr/mesh/D000086942",
"about": {
"@type": "MedicalCondition",
"name": "Enveloppe virale",
"code": {
"@type": "MedicalCode",
"code": "D000086942",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A21.249.750"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Virion",
"alternateName": "Virion",
"code": {
"@type": "MedicalCode",
"code": "D014771",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Tibor Füzik",
"url": "https://questionsmedicales.fr/author/Tibor%20F%C3%BCzik",
"affiliation": {
"@type": "Organization",
"name": "Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic."
}
},
{
"@type": "Person",
"name": "Pavel Plevka",
"url": "https://questionsmedicales.fr/author/Pavel%20Plevka",
"affiliation": {
"@type": "Organization",
"name": "Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic pavel.plevka@ceitec.muni.cz."
}
},
{
"@type": "Person",
"name": "Liya Mukhamedova",
"url": "https://questionsmedicales.fr/author/Liya%20Mukhamedova",
"affiliation": {
"@type": "Organization",
"name": "Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic."
}
},
{
"@type": "Person",
"name": "Antonín Přidal",
"url": "https://questionsmedicales.fr/author/Anton%C3%ADn%20P%C5%99idal",
"affiliation": {
"@type": "Organization",
"name": "Department of Zoology, Fishery, Hydrobiology, and Apidology, Faculty of Agronomy, Mendel University in Brno, Zemědělská 1/1665, 613 00 Brno, Czech Republic."
}
},
{
"@type": "Person",
"name": "Michael Way",
"url": "https://questionsmedicales.fr/author/Michael%20Way",
"affiliation": {
"@type": "Organization",
"name": "Cellular Signalling and Cytoskeletal Function Laboratory, The Francis Crick Institute, London, United Kingdom."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Shortened time to neuromuscular recovery with lower doses of rocuronium in elderly patients.",
"datePublished": "2024-05-13",
"url": "https://questionsmedicales.fr/article/38847412",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.61409/A09230578"
}
},
{
"@type": "ScholarlyArticle",
"name": "Use of neuromuscular blockade for neck dissection and association with iatrogenic nerve injury.",
"datePublished": "2023-07-28",
"url": "https://questionsmedicales.fr/article/37507689",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12871-023-02217-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Peri-operative management of neuromuscular blockade: A guideline from the European Society of Anaesthesiology and Intensive Care.",
"datePublished": "2022-11-15",
"url": "https://questionsmedicales.fr/article/36377554",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1097/EJA.0000000000001769"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Nonirritating Concentrations of Neuromuscular Blocking Agents and Related Compounds.",
"datePublished": "2022-09-13",
"url": "https://questionsmedicales.fr/article/36108924",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jaip.2022.08.049"
}
},
{
"@type": "ScholarlyArticle",
"name": "Rapid detection of rocuronium based on host/guest complex between a pyrene derivative and sugammadex.",
"datePublished": "2022-08-23",
"url": "https://questionsmedicales.fr/article/36027682",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jpba.2022.115014"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Structures virales",
"item": "https://questionsmedicales.fr/mesh/D056224"
},
{
"@type": "ListItem",
"position": 3,
"name": "Virion",
"item": "https://questionsmedicales.fr/mesh/D014771"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Virion - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Virion",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Virion",
"description": "Comment identifier un virion dans un échantillon ?\nQuels tests sont utilisés pour détecter les virions ?\nLes virions peuvent-ils être visualisés au microscope ?\nQuelle est la méthode de culture des virions ?\nLes tests sérologiques détectent-ils les virions ?",
"url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Androstanols#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Virion",
"description": "Quels symptômes indiquent une infection virale ?\nLes virions causent-ils toujours des symptômes ?\nComment les symptômes varient-ils selon le virion ?\nLes symptômes d'une infection virale sont-ils immédiats ?\nLes virions peuvent-ils provoquer des symptômes neurologiques ?",
"url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Androstanols#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Virion",
"description": "Comment prévenir les infections virales ?\nLes masques protègent-ils contre les virions ?\nLes vaccins sont-ils efficaces contre tous les virions ?\nL'hygiène personnelle aide-t-elle à prévenir les infections ?\nLes voyages augmentent-ils le risque d'infection virale ?",
"url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Androstanols#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Virion",
"description": "Quels traitements sont efficaces contre les virions ?\nLes antibiotiques sont-ils efficaces contre les virions ?\nComment les vaccins agissent-ils contre les virions ?\nLes traitements symptomatiques sont-ils utiles ?\nLes traitements antiviraux sont-ils toujours efficaces ?",
"url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Androstanols#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Virion",
"description": "Quelles complications peuvent survenir après une infection virale ?\nLes virions peuvent-ils causer des maladies chroniques ?\nComment les complications sont-elles gérées ?\nLes complications varient-elles selon le virion ?\nLes enfants sont-ils plus à risque de complications ?",
"url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Androstanols#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Virion",
"description": "Quels sont les facteurs de risque d'infection virale ?\nLe stress affecte-t-il le risque d'infection virale ?\nLes maladies chroniques augmentent-elles le risque d'infection ?\nL'environnement joue-t-il un rôle dans le risque viral ?\nLes habitudes alimentaires influencent-elles le risque viral ?",
"url": "https://questionsmedicales.fr/mesh/D014771?mesh_terms=Androstanols#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier un virion dans un échantillon ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'identification se fait par microscopie électronique ou tests PCR."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour détecter les virions ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests PCR, les cultures virales et les tests sérologiques sont courants."
}
},
{
"@type": "Question",
"name": "Les virions peuvent-ils être visualisés au microscope ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les virions peuvent être visualisés au microscope électronique."
}
},
{
"@type": "Question",
"name": "Quelle est la méthode de culture des virions ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les virions sont cultivés dans des cellules hôtes appropriées en laboratoire."
}
},
{
"@type": "Question",
"name": "Les tests sérologiques détectent-ils les virions ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils détectent les anticorps contre les virions, pas les virions eux-mêmes."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une infection virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, douleurs musculaires et symptômes respiratoires sont fréquents."
}
},
{
"@type": "Question",
"name": "Les virions causent-ils toujours des symptômes ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, certains virions peuvent être asymptomatiques chez l'hôte."
}
},
{
"@type": "Question",
"name": "Comment les symptômes varient-ils selon le virion ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes dépendent du type de virus et de l'hôte infecté."
}
},
{
"@type": "Question",
"name": "Les symptômes d'une infection virale sont-ils immédiats ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, il peut y avoir une période d'incubation avant l'apparition des symptômes."
}
},
{
"@type": "Question",
"name": "Les virions peuvent-ils provoquer des symptômes neurologiques ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains virions, comme ceux de la grippe, peuvent affecter le système nerveux."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections virales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains, éviter les contacts étroits et se faire vacciner sont essentiels."
}
},
{
"@type": "Question",
"name": "Les masques protègent-ils contre les virions ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les masques réduisent la transmission des virions par voie respiratoire."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils efficaces contre tous les virions ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque vaccin cible des virions spécifiques et ne protège pas contre tous."
}
},
{
"@type": "Question",
"name": "L'hygiène personnelle aide-t-elle à prévenir les infections ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une bonne hygiène personnelle réduit le risque d'infections virales."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection virale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent exposer à de nouveaux virions et augmenter le risque d'infection."
}
},
{
"@type": "Question",
"name": "Quels traitements sont efficaces contre les virions ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux, comme l'oseltamivir, sont utilisés pour traiter certaines infections virales."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les virions ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales."
}
},
{
"@type": "Question",
"name": "Comment les vaccins agissent-ils contre les virions ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins stimulent le système immunitaire à reconnaître et combattre les virions."
}
},
{
"@type": "Question",
"name": "Les traitements symptomatiques sont-ils utiles ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils aident à soulager les symptômes, mais ne traitent pas l'infection virale."
}
},
{
"@type": "Question",
"name": "Les traitements antiviraux sont-ils toujours efficaces ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, leur efficacité dépend du type de virus et de la résistance virale."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une infection virale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la pneumonie, la déshydratation ou des infections secondaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les virions peuvent-ils causer des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains virions, comme le VIH, peuvent entraîner des maladies chroniques."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications sont gérées par des traitements symptomatiques et des soins médicaux appropriés."
}
},
{
"@type": "Question",
"name": "Les complications varient-elles selon le virion ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virion peut entraîner des complications différentes selon l'hôte."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque de complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les enfants peuvent être plus vulnérables aux complications des infections virales."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque d'infection virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'âge, le système immunitaire affaibli et l'exposition à des porteurs."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il le risque d'infection virale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress peut affaiblir le système immunitaire et augmenter le risque d'infection."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque d'infection ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies chroniques peuvent affaiblir l'immunité et augmenter le risque d'infection virale."
}
},
{
"@type": "Question",
"name": "L'environnement joue-t-il un rôle dans le risque viral ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des environnements surpeuplés ou insalubres augmentent le risque d'infections virales."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires influencent-elles le risque viral ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation déséquilibrée peut affaiblir le système immunitaire et augmenter le risque."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 09/03/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic.
Publications dans "Virion" :
3 publications dans cette catégorie
Affiliations :
Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic pavel.plevka@ceitec.muni.cz.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Structural Virology Group, Central European Institute of Technology, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Department of Zoology, Fishery, Hydrobiology, and Apidology, Faculty of Agronomy, Mendel University in Brno, Zemědělská 1/1665, 613 00 Brno, Czech Republic.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Cellular Signalling and Cytoskeletal Function Laboratory, The Francis Crick Institute, London, United Kingdom.
Department of Infectious Disease, Imperial College, London, United Kingdom.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Central European Institute of Technology, Masaryk University, Kamenice 753/5, Brno, 625 00, Czech Republic.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Waksman Institute for Microbiology, Rutgers, The State University of New Jersey, Piscataway, NJ, 08854, USA.
Department of Biochemistry and Molecular Biology, Thomas Jefferson University, Philadelphia, 19107, USA.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Department of Cell Biology and Neuroscience, Rowan University School of Osteopathic Medicine at Stratford, Stratford, NJ, 08084-1489, USA.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, 20894, USA.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, 20894, USA.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Center of Life Sciences, Skolkovo Institute of Science and Technology, Moscow, 121205, Russia. maria.sokolova@mpinat.mpg.de.
Department of Molecular Biology, Max Planck Institute for Multidisciplinary Sciences, Göttingen, 37077, Germany. maria.sokolova@mpinat.mpg.de.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology & Cell Biology, Montana State Universitygrid.41891.35, Bozeman, Montana, USA.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology & Cell Biology, Montana State Universitygrid.41891.35, Bozeman, Montana, USA.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Department of Microbiology & Cell Biology, Montana State Universitygrid.41891.35, Bozeman, Montana, USA.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Weizmann Institute of Science, Rehovot 7610001, Israel.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Weizmann Institute of Science, Rehovot 7610001, Israel.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Weizmann Institute of Science, Rehovot 7610001, Israel.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
California Institute of Technology, Pasadena, CA 91125, USA.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
California Institute of Technology, Pasadena, CA 91125, USA.
Chan Zuckerberg Biohub, 499 Illinois Street, SF CA 94158, USA.
Publications dans "Virion" :
2 publications dans cette catégorie
Affiliations :
Weizmann Institute of Science, Rehovot 7610001, Israel.
Publications dans "Virion" :
The effect of neuromuscular blocking agents may be reversed by administration of neostigmine, when two twitches are present using train-of-four (TOF) stimulation. However, in elderly patients, limited...
This was a secondary analysis of 50 elderly patients > 80 years; 16 patients received rocuronium 0.6 mg/kg, another 16 patients received rocuronium 0.9 mg/kg; and, finally, 18 patients received rocuro...
Time to TOF-2 was shorter after rocuronium 0.6 mg/kg than after rocuronium 0.9 mg/kg: 37 min. versus 59 min. (difference: 22 min. (95% confidence intervals (CI): 10 to 33 min.), p = 0.0007). Time to T...
Time to TOF-2 was shorter after rocuronium 0.6 mg/kg than after 0.9 mg/kg and shorter after rocuronium 0.3 mg/kg than after 0.6 mg/kg....
This work was supported by departmental sources....
This study was a secondary analysis of two clinical trials....
gov (NCT04512313), (NCT03857750)....
Cranial nerve injury is an uncommon but significant complication of neck dissection. We examined the association between the use of intraoperative neuromuscular blockade and iatrogenic cranial nerve i...
This was a single-center, retrospective, electronic health record review. Study inclusion criteria stipulated patients > 18 years who had ≥ 2 neck lymphatic levels dissected for malignancy under gener...
Our cohort consisted of 925 distinct neck dissections performed in 897 patients. Neuromuscular blockade was used during 285 (30.8%) neck dissections. Fourteen instances (1.5% of surgical cases) of ner...
In this study, use of neuromuscular blockade intraoperatively during neck dissection was not associated with increased rates of iatrogenic cranial nerve injury. While this investigation provides early...
Recent data indicated a high incidence of inappropriate management of neuromuscular block, with a high rate of residual paralysis and relaxant-associated postoperative complications. These data are al...
Skin testing (ST) concentrations of neuromuscular blocking agents (NMBAs), NMBA-reversal agents, and the sugammadex-rocuronium inclusion complex (S-R-Cx) vary widely among reports....
To determine maximal ST nonirritant concentrations (NICs) of NMBAs (cisatracurium, rocuronium, succinylcholine, and vecuronium), NMBA-reversal agents (neostigmine and sugammadex), and S-R-Cx in NMBA-t...
A single-center, prospective study between October 2019 and November 2021 of adult participants with or without a planned surgical procedure. The reference standard was tolerance of medication tested ...
A total of 187 participants (78% NMBA-tolerant) underwent 7812 skin tests. All undiluted SPT concentrations were nonirritant. We found the following maximal IDT NICs (mg/mL): cisatracurium (0.02), roc...
Our results suggest that SPT may be performed with undiluted stock concentrations. We confirm maximal IDT NICs for cisatracurium and rocuronium. We also propose that currently recommended maximal IDT ...
Rocuronium is widely used in surgery as a neuromuscular relaxant, but it has been difficult to accurately control its specific dosage in clinical operation. Therefore, the development of fast and inst...
The level of neuromuscular blockade can be assessed by subjective (qualitative) and objective (quantitative) methods. This study aims to compare the dosage of the neuromuscular blocking agents (NMBA) ...
Residual neuromuscular blockade is a common complication after general anaesthesia. Sugammadex can reverse the action of aminosteroid neuromuscular blockers. This study aimed to explore sugammadex saf...
All sugammadex-related adverse events reported in VigiBase between 2010 and 2019 were classified by group queries according to the Medical Dictionary for Regulatory Activities. A disproportionality an...
Overall, 16 219 410 adverse events were reported and 2032 were associated with sugammadex. The frequent reactions were recurrence of neuromuscular blockade (n = 54, IC 6.74, IC...
Anaesthesiologists should carefully monitor the anaesthesia recovery period to correct the ADRs caused by sugammadex and recommend monitoring neuromuscular function throughout the anaesthesia process....
To compare outcomes between two standard-of-care anesthesia regimens for operative laryngoscopy: general anesthesia with a neuromuscular blocking agent (NMBA) versus remifentanil and propofol (non-NMB...
This was a prospective, single-blinded, randomized controlled trial at a tertiary care center. Patients were randomized to either anesthesia using rocuronium (NMBA) or with remifentanil/propofol infus...
Sixty-one patients who underwent suspension laryngoscopy from 2020 to 2022 were included (25 female, 36 male, ranging 20-81 years). Thirty patients were enrolled in the NMBA arm and 31 patients in the...
Anesthesia with rocuronium was associated with better intraoperative conditions and postoperative pain compared to anesthesia with remifentanil/propofol. Remifentanil/propofol were associated with low...
2 Laryngoscope, 133:2654-2664, 2023....
This is a prospective, observational study. Patients between the ages of 18 and 65 with BMI of 18.5-34.9, who are expected to be under general anesthesia for less than 6 hours, were divided into 3 gro...
In Group 1,...
In adult patients with a BMI of 18.5 and 24.9 BMI, we report optimal intubation conditions with the LBW-adjusted rocuronium dosage. This trial is registered with NCT05476952....
The study aimed to compare the responses obtained simultaneously from the newly developed electromyography (EMG)-based neuromuscular monitors, AF-201P and TetraGraph™, during rocuronium-induced neurom...
Twenty patients were enrolled in this study. During total intravenous general anesthesia, train-of-four (TOF) responses following 0.9-mg/kg-rocuronium administration were monitored at the abductor dig...
A total of 19 patients were analyzed. The supramaximal current was significantly lower with AF-201P than TetraGraph (31.7 ± 13.2 vs. 43.2 ± 8.2, p = .002). The time to first PTC (24.9 ± 9.4 vs. 27.3 ±...
AF-201P showed faster recovery of rocuronium-induced neuromuscular block compared with TetraGraph....